Semaglutide 30mg
For In Vitro Use Only — Not for Human Use
Long-acting GLP-1 receptor analogue — 30mg lyophilised vial at ≥98% purity for in vitro incretin and receptor-binding research.
- Peptide Type
- Long-acting GLP-1 receptor analogue
- Sequence length
- 31 amino acids
- Molecular weight
- ≈4,113 Da
- Form
- Lyophilised powder
- Quantity
- 30mg per vial
- Purity
- ≥98% by RP-HPLC + MS
- Solubility
- Water / bacteriostatic water
- CAS
- 910463-68-2
Product Overview
Semaglutide is a long-acting 31-residue GLP-1 receptor analogue with a C18 fatty-diacid modification at Lys26 that extends its plasma half-life relative to native GLP-1. Supplied as a 30mg sterile lyophilised powder, verified to ≥98% purity by RP-HPLC and confirmed by mass spectrometry.
Research Overview
Semaglutide is a reference GLP-1 agonist in in vitro receptor pharmacology — used to characterise cAMP response, β-arrestin recruitment, receptor internalisation and comparator responses when benchmarking dual (Tirzepatide) and triple (Retatrutide) agonists.
Handling & Use
Reconstitute the 30mg vial with bacteriostatic water in a sterile environment. Semaglutide's fatty-acid modification supports good stability in refrigerated aqueous solution — prepare working aliquots to avoid repeated freeze-thaw cycles.
Storage Guidelines
- Lyophilised vials: store below -18°C, protected from light.
- Reconstituted solution: refrigerate at 2–8°C and use within 30 days.
- Avoid repeated freeze-thaw cycles to preserve peptide integrity.
- Strictly for laboratory research use only.
- Not for human or veterinary use.
- Not intended to diagnose, treat, cure, or prevent any condition.
Frequently asked questions
What is Semaglutide used for in research?+
Semaglutide is a reference GLP-1 receptor analogue used in vitro to study receptor binding, cAMP signalling, β-arrestin recruitment and comparator pharmacology against dual and triple agonists such as Tirzepatide and Retatrutide.
What is the reported half-life of Semaglutide?+
Published pharmacokinetic literature reports a half-life of approximately 7 days, enabled by the C18 fatty-diacid modification at Lys26 that binds albumin. This supports once-weekly administration in research protocols.
What purity is your Semaglutide?+
Every 30mg vial is tested to ≥98% purity by RP-HPLC and confirmed by mass spectrometry (~4,113 Da). A batch-specific COA is published on our COA page.
How is the 30mg vial reconstituted?+
Reconstitute with bacteriostatic water in a sterile laboratory environment. For target concentrations and volumes, use our peptide calculator.
How does Semaglutide compare with Tirzepatide?+
Semaglutide activates the GLP-1 receptor only; Tirzepatide is a dual GLP-1 / GIP agonist. The second receptor is the main variable researchers compare when characterising incretin pharmacology.
How long is reconstituted Semaglutide stable?+
Kept refrigerated at 2–8°C and protected from light, reconstituted Semaglutide remains suitable for in vitro research use for up to ~30 days. Avoid repeated freeze-thaw cycles.
Do you ship Semaglutide from the UK?+
Yes — all Semaglutide vials are UK-stocked with next-working-day dispatch on orders placed before 2pm.
